Yield10 Bioscience, Inc. (YTEN)

Market Cap	387.90K
Revenue (ttm)	750.00K
Net Income (ttm)	-12.70M
Shares Out	692.68K
EPS (ttm)	-24.93
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	295
Open	0.600
Previous Close	0.600
Day's Range	0.600 - 0.610
52-Week Range	0.530 - 17.280
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2024

About Yield10 Bioscience

Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscienc...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 1992
• Employees: 29
• Stock Exchange: OTCMKTS
• Ticker Symbol: YTEN

Financial Performance

In 2023, Yield10 Bioscience's revenue was $60,000, a decrease of -86.67% compared to the previous year's $450,000. Losses were -$14.46 million, 6.55% more than in 2022.